JANXJanux Therapeutics, Inc.
What is the market doing?
No clear lean: rangebound and heavily shorted.
Choppy, but holding above its 200-day average. Price is +9% vs its 200-day average.
Heavily shorted, settled Sep 30, 2026, about a week of normal trading to cover.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How JANX is trading
Janux Therapeutics, Inc. is −37% over the past year while the S&P 500 is +16%: 53 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +9.3%
vs 200-day average · close to trend
- RSI (14)
- 51
RSI (14) · neutral
- Below its 52-week high
- 52%
Below its 52-week high
Details›
- Last close2026-10-23
- $16.65
- 1 monthS&P 500 −0.94%
- −0.09%
- 1 yearS&P 500 +16%
- −37%
- 5 yearsS&P 500 +86%
- −21%
- vs 50-day average$17.53
- −5.0%
- 52-week high
- $34.74
- 52-week low
- $12.18
- Annualised volatility
- 76%
- Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
- $86K
| Year | Return |
|---|---|
| 2026 (year to date) | +21% |
| 2025 | −74% |
| 2024 | +399% |
| 2023 | −19% |
| 2022 | −33% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 1 of 5 | +1.2% |
| Feb | 5 | 2 of 5 | +86% |
| Mar | 5 | 1 of 5 | −16% |
| Apr | 5 | 4 of 5 | +15% |
| May | 5 | 2 of 5 | −8.8% |
| Jun | 5 | 3 of 5 | −1.5% |
| Jul | 6 | 4 of 6 | +8.2% |
| Aug | 6 | 3 of 6 | +0.19% |
| Sep | 6 | 2 of 6 | −3.4% |
| Oct | 6 | 4 of 6 | +7.1% |
| Nov | 5 | 2 of 5 | −2.6% |
| Dec | 5 | 3 of 5 | −2.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.